The Library
Exenatide prolonged-release suspension for injection in combination with oral antidiabetic therapy for the treatment of type 2 diabetes
Tools
Tools
Tools
Waugh, Norman, Cummins, E. (Ewen), Shyangdan, D. (Deepson), Court, Rachel A. and Mohiuddin, Syed (2012) Exenatide prolonged-release suspension for injection in combination with oral antidiabetic therapy for the treatment of type 2 diabetes. Manchester: National Institute for Health and Clinical Excellence (NICE). (NICE technology appraisal guidance).
|
Text
WRAP_Waugh_Exenatide_prolonged_release.pdf - Published Version Download (287Kb) | Preview |
Official URL: http://www.nice.org.uk/ta248
Abstract
Prolonged-release exenatide in triple therapy regimens (that is, in combination
with metformin and a sulphonylurea, or metformin and a thiazolidinedione) is
recommended as a treatment option for people with type 2 diabetes as
described in 'Type 2 diabetes: the management of type 2 diabetes (NICE
clinical guideline 87); that is, when control of blood glucose remains or
becomes inadequate (HbA1c ≥ 7.5% [59 mmol/mol] or other higher level agreed
with the individual), and the person has:
a body mass index (BMI) ≥ 35 kg/m2 in those of European family origin (with
appropriate adjustment for other ethnic groups) and specific psychological or
medical problems associated with high body weight or
a BMI < 35 kg/m2, and therapy with insulin would have significant occupational
implications or weight loss would benefit other significant obesity-related
comorbidities.
| Item Type: | Report |
|---|---|
| Subjects: | R Medicine > RC Internal medicine R Medicine > RM Therapeutics. Pharmacology |
| Divisions: | Faculty of Medicine > Warwick Medical School > Health Sciences > Population, Evidence & Technologies (PET) > Warwick Evidence Faculty of Medicine > Warwick Medical School > Health Sciences Faculty of Medicine > Warwick Medical School |
| Library of Congress Subject Headings (LCSH): | Non-insulin-dependent diabetes -- Treatment |
| Series Name: | NICE technology appraisal guidance |
| Publisher: | National Institute for Health and Clinical Excellence (NICE) |
| Place of Publication: | Manchester |
| Official Date: | February 2012 |
| Volume: | No.248 |
| Number of Pages: | 55 |
| Status: | Peer Reviewed |
| Publication Status: | Published |
| Access rights to Published version: | Restricted or Subscription Access |
| URI: | http://wrap.warwick.ac.uk/id/eprint/46363 |
Actions (login required)
 |
View Item |
